T
Tarak D. Mody
Researcher at University of Texas at Austin
Publications - 50
Citations - 3117
Tarak D. Mody is an academic researcher from University of Texas at Austin. The author has contributed to research in topics: Texaphyrin & Porphyrin. The author has an hindex of 25, co-authored 50 publications receiving 3055 citations. Previous affiliations of Tarak D. Mody include University of Texas System.
Papers
More filters
Patent
Texaphyrin-oligonucleotide conjugates
TL;DR: In this paper, the use of texaphyrin as a radiation sensitizer for treating the hypoxic areas of solid neoplasms is discussed, where the authors provide a low redox potential which allows radiation-induced hydrated electrons to flow to texaphrin rather than neutralizing hydroxyl radicals.
Patent
Texaphyrin compounds having improved functionalization
TL;DR: In this paper, electron-donating groups at positions 2, 7, 12, 15, 18 and/or 21 contribute electrons to the aromatic π system of the macrocycle which stabilizes the metal complex to demetallation and the imine bonds to hydrolysis.
Journal ArticleDOI
Texaphyrins: Synthesis and Applications
Jonathan L. Sessler,Gregory W. Hemmi,Tarak D. Mody,Toshiaki Murai,Toshiaki Murai,Anthony K. Burrell,Anthony K. Burrell,Stuart W. Young +7 more
Journal ArticleDOI
Gadolinium(III) texaphyrin: a tumor selective radiation sensitizer that is detectable by MRI
Stuart W. Young,Fan Qing,Anthony Harriman,Jonathan L. Sessler,William C. Dow,Tarak D. Mody,Gregory W. Hemmi,Yunpeng Hao,Richard A. Miller +8 more
TL;DR: Gadolinium(III) texaphyrin (Gd-tex2+) was found to be an efficient radiation sensitizer in studies carried out with HT29 cells in in vitro as well as in in vivo single and multifraction irradiation studies with a murine mammary carcinoma model.
Journal ArticleDOI
Synthesis and structural characterization of lanthanide(III) texaphyrins
TL;DR: In this paper, the synthesis and characterization of several lanthanide(III) texaphyrin complexes of 4, 5, 9, 24-tetraethyl-16, 17-dimethoxy-10, 23-dimethyl-13, 20, 25, 26, 27-pentaazapentacyclo[20.1.2.